Document is current

Article History

Received: 26 July 2023

Accepted: 14 November 2023

First Online: 27 November 2023

Declarations

:

: This trial was approved by the University of Washington Human Subjects Division and the University of Nairobi-Kenyatta National Hospital Ethics and Research Committee. The Mombasa County DOH endorsed this work as a county-supported public health activity, and clinic managers were asked to provide assent for their clinics’ participation. The clinic staff provided verbal assent to participate in structured interviews. The FP register data were fully de-identified, so consent was not required from individual FP clients.

: Not applicable.

: RSM has received STI testing supplies, provided to the University of Washington, from Hologic Corporation. RVB declares support from the US National Institutes of Health, the Bill and Melinda Gates Foundation, and the World Health Organization. Regeneron Pharmaceuticals covered abstract and manuscript writing costs outside the submitted work. RVB serves on a Gilead Sciences DMC, for which she receives an honorarium. The other authors declare that they have no competing interests.